Study Protocol - Efficacy and Safety of Pegylated-Proline-Interferon Alpha 2b (Aop2014) in Maintaining Deep Molecular Remissions in Patients with Chronic Myeloid Leukemia (CML) who Discontinue ABL-Kinase Inhibitor Therapy
Version 1

No description specified

SEEK ID: https://ldh.kks-marburg.imise.uni-leipzig.de/documents/5?version=1

Filename: ENDURE_CML_Study Protocol_V07F_2021-03-01.pdf 

Format: PDF document

Size: 1.03 MB

help Creators and Submitter
Activity

Views: 51   Downloads: 0

Created: 27th Nov 2024 at 12:44

help Tags

This item has not yet been tagged.

help Attributions

None

Version History

Version 1 (earliest) Created 27th Nov 2024 at 12:44 by Gerrit zur Hausen

No revision comments

Powered by
(v.1.16.1)
Copyright © 2008 - 2023 The University of Manchester and HITS gGmbH